Tag Archives: Cell

Promising new sickle cell disease medicine wins FDA approval

This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP) After a recent decision by the FDA a better day could be… Read More »

Cell injection could train the body not to reject organ transplants

By Clare Wilson People with organ transplants currently have to take drugs to stop the donor organ being rejectedCraig Stennett/Alamy A one-off injection of cells could be a long-sought solution to the problem of the body rejecting an organ transplant. The first person who may have benefited from this approach is an Italian man who… Read More »

Vaping flavored Juul pods damages lung cell DNA, raising cancer risks

Juul pod flavors like creme brulee, menthol and mint blamed for getting teens hooked on vaping raise risks for lung injuries and cancer by damaging DNA, study suggests Sweet e-cigarette liquid flavors have been blamed for getting teenagers addicted to vaping  But little is known about how the chemicals in these flavors may affect the… Read More »

FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease

FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease Print this page SOUTH SAN FRANCISCO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) —  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta™ (voxelotor) tablets for the treatment of sickle cell disease (SCD) in adults and children… Read More »

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults Print this page Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive… Read More »